KPIs & Operating Metrics(New)
Growth Metrics

Bristol Myers Squibb (BMY) Enterprise Value Growth (1y) (2010 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Novartis Ag 107,124,802.25 Bn 107,124,802.25 Bn -
2 Eli Lilly 969.00 Bn 963.72 Bn 16.22 Bn
3 Johnson & Johnson 539.46 Bn 517.41 Bn 15.96 Bn
4 AbbVie 376.92 Bn 367.57 Bn 10.78 Bn
5 Merck 285.00 Bn 279.35 Bn 12.09 Bn
6 Amgen 177.58 Bn 165.55 Bn 5.87 Bn
7 Gilead Sciences 163.22 Bn 155.50 Bn 5.52 Bn
8 Pfizer 145.86 Bn 133.09 Bn -1.21 Bn
9 Bristol Myers Squibb 111.90 Bn 101.44 Bn 8.07 Bn
10 Gsk 88.34 Bn 83.66 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 10.84%
Dec 31, 2025 1.54%
Sep 30, 2025 -104.75%
Jun 30, 2025 -105.32%
Mar 31, 2025 -21.96%
Dec 31, 2024 11.61%
Sep 30, 2024 -5.45%
Jun 30, 2024 23.91%
Mar 31, 2024 -4.40%
Dec 31, 2023 -32.94%
Sep 30, 2023 14.98%
Jun 30, 2023 34.13%
Mar 31, 2023 38.22%
Dec 31, 2022 45.61%
Sep 30, 2022 42.51%
Jun 30, 2022 -2.04%
Mar 31, 2022 -15.87%
Dec 31, 2021 -7.20%
Sep 30, 2021 26.04%
Jun 30, 2021 40.24%
Mar 31, 2021 29.55%
Dec 31, 2020 -3.13%
Sep 30, 2020 35.00%
Jun 30, 2020 26.19%
Mar 31, 2020 -110.69%
Dec 31, 2019 -76.53%
Sep 30, 2019 -382.68%
Jun 30, 2019 -389.71%
Mar 31, 2019 -30.16%
Dec 31, 2018 19.29%
Sep 30, 2018 3.88%
Jun 30, 2018 6.41%
Mar 31, 2018 -11.14%
Dec 31, 2017 -73.69%
Sep 30, 2017 -29.66%
Jun 30, 2017 -42.13%
Mar 31, 2017 -44.62%
Dec 31, 2016 -50.29%
Sep 30, 2016 -3.31%
Jun 30, 2016 15.39%
Mar 31, 2016 44.51%
Dec 31, 2015 43.70%
Sep 30, 2015 27.14%
Jun 30, 2015 25.48%
Mar 31, 2015 -6.61%
Dec 31, 2014 -64.39%
Sep 30, 2014 -162.00%
Jun 30, 2014 -154.67%
Mar 31, 2014 -180.83%
Dec 31, 2013 -57.89%
Sep 30, 2013 6.69%
Jun 30, 2013 47.45%
Mar 31, 2013 51.31%
Dec 31, 2012 68.10%
Sep 30, 2012 64.82%
Jun 30, 2012 32.43%
Mar 31, 2012 25.69%
Dec 31, 2011 -19.60%
Sep 30, 2011 26.92%
Jun 30, 2011 17.93%
Mar 31, 2011 14.21%
Dec 31, 2010 13.95%
Sep 30, 2010 -29.04%
Jun 30, 2010 -0.20%
Mar 31, 2010 -823.10%